Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $15.10 billion. The enterprise value is $15.74 billion.
| Market Cap | 15.10B |
| Enterprise Value | 15.74B |
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 222.42 million shares outstanding. The number of shares has decreased by -4.25% in one year.
| Current Share Class | 222.42M |
| Shares Outstanding | 222.42M |
| Shares Change (YoY) | -4.25% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 104.61% |
| Float | 220.31M |
Valuation Ratios
The trailing PE ratio is 28.13 and the forward PE ratio is 15.35. Hologic's PEG ratio is 1.92.
| PE Ratio | 28.13 |
| Forward PE | 15.35 |
| PS Ratio | 3.84 |
| Forward PS | 3.50 |
| PB Ratio | 3.12 |
| P/TBV Ratio | 27.15 |
| P/FCF Ratio | 16.20 |
| P/OCF Ratio | 14.13 |
| PEG Ratio | 1.92 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.61, with an EV/FCF ratio of 16.89.
| EV / Earnings | 28.26 |
| EV / Sales | 3.90 |
| EV / EBITDA | 12.61 |
| EV / EBIT | 16.63 |
| EV / FCF | 16.89 |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.52.
| Current Ratio | 3.55 |
| Quick Ratio | 2.59 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 1.96 |
| Debt / FCF | 2.71 |
| Interest Coverage | 7.86 |
Financial Efficiency
Return on equity (ROE) is 11.38% and return on invested capital (ROIC) is 7.95%.
| Return on Equity (ROE) | 11.38% |
| Return on Assets (ROA) | 6.69% |
| Return on Invested Capital (ROIC) | 7.95% |
| Return on Capital Employed (ROCE) | 12.07% |
| Revenue Per Employee | $577,811 |
| Profits Per Employee | $79,700 |
| Employee Count | 6,990 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, Hologic has paid $118.50 million in taxes.
| Income Tax | 118.50M |
| Effective Tax Rate | 17.54% |
Stock Price Statistics
The stock price has decreased by -18.81% in the last 52 weeks. The beta is 0.49, so Hologic's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -18.81% |
| 50-Day Moving Average | 64.29 |
| 200-Day Moving Average | 67.30 |
| Relative Strength Index (RSI) | 64.30 |
| Average Volume (20 Days) | 1,863,813 |
Short Selling Information
The latest short interest is 5.15 million, so 2.31% of the outstanding shares have been sold short.
| Short Interest | 5.15M |
| Short Previous Month | 5.58M |
| Short % of Shares Out | 2.31% |
| Short % of Float | 2.34% |
| Short Ratio (days to cover) | 2.16 |
Income Statement
In the last 12 months, Hologic had revenue of $4.04 billion and earned $557.10 million in profits. Earnings per share was $2.41.
| Revenue | 4.04B |
| Gross Profit | 2.46B |
| Operating Income | 946.50M |
| Pretax Income | 789.10M |
| Net Income | 557.10M |
| EBITDA | 1.25B |
| EBIT | 946.50M |
| Earnings Per Share (EPS) | $2.41 |
Balance Sheet
The company has $1.88 billion in cash and $2.52 billion in debt, giving a net cash position of -$639.20 million or -$2.87 per share.
| Cash & Cash Equivalents | 1.88B |
| Total Debt | 2.52B |
| Net Cash | -639.20M |
| Net Cash Per Share | -$2.87 |
| Equity (Book Value) | 4.84B |
| Book Value Per Share | 21.79 |
| Working Capital | 2.46B |
Cash Flow
In the last 12 months, operating cash flow was $1.07 billion and capital expenditures -$136.90 million, giving a free cash flow of $932.10 million.
| Operating Cash Flow | 1.07B |
| Capital Expenditures | -136.90M |
| Free Cash Flow | 932.10M |
| FCF Per Share | $4.19 |
Margins
Gross margin is 60.86%, with operating and profit margins of 23.43% and 13.79%.
| Gross Margin | 60.86% |
| Operating Margin | 23.43% |
| Pretax Margin | 16.73% |
| Profit Margin | 13.79% |
| EBITDA Margin | 30.92% |
| EBIT Margin | 23.43% |
| FCF Margin | 23.08% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.25% |
| Shareholder Yield | 4.25% |
| Earnings Yield | 3.69% |
| FCF Yield | 6.17% |
Analyst Forecast
The average price target for Hologic is $74.73, which is 10.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $74.73 |
| Price Target Difference | 10.04% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 5.11% |
| EPS Growth Forecast (5Y) | 10.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.13 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.13 |
| Piotroski F-Score | 6 |